Kamada’s centers plan ~50,000 liters of plasma each at full capacity
Kamada (NASDAQ: KMDA) announced a new three-year agreement to supply normal source plasma, expected to generate approximately $50 million in revenue. This plasma will come from its FDA-approved collection centers in Houston and San Antonio, Texas, each designed for a planned capacity of about …
Sharemaestro market context Price below Trend Line 52 weeks -6.4%